JP2025500826A5 - - Google Patents
Info
- Publication number
- JP2025500826A5 JP2025500826A5 JP2024534762A JP2024534762A JP2025500826A5 JP 2025500826 A5 JP2025500826 A5 JP 2025500826A5 JP 2024534762 A JP2024534762 A JP 2024534762A JP 2024534762 A JP2024534762 A JP 2024534762A JP 2025500826 A5 JP2025500826 A5 JP 2025500826A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- composition according
- compound
- ckd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289177P | 2021-12-14 | 2021-12-14 | |
| US63/289,177 | 2021-12-14 | ||
| PCT/US2022/052631 WO2023114170A1 (en) | 2021-12-14 | 2022-12-13 | Aldosterone synthase inhibitors for treating chronic kidney disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500826A JP2025500826A (ja) | 2025-01-15 |
| JP2025500826A5 true JP2025500826A5 (https=) | 2026-01-07 |
Family
ID=85151059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534762A Pending JP2025500826A (ja) | 2021-12-14 | 2022-12-13 | 慢性腎疾患を処置するためのアルドステロンシンターゼ阻害薬 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12263157B2 (https=) |
| EP (1) | EP4447961A1 (https=) |
| JP (1) | JP2025500826A (https=) |
| KR (1) | KR20240122521A (https=) |
| CN (1) | CN118401241A (https=) |
| AR (1) | AR127948A1 (https=) |
| AU (1) | AU2022415313A1 (https=) |
| CA (1) | CA3236890A1 (https=) |
| CL (1) | CL2024001470A1 (https=) |
| MX (1) | MX2024007335A (https=) |
| TW (1) | TW202339719A (https=) |
| WO (1) | WO2023114170A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025019546A1 (en) * | 2023-07-17 | 2025-01-23 | Mineralys Therapeutics, Inc. | Methods of treating chronic kidney disease (ckd) or ckd and hypertension with lorundrostat, or a combination of lorundrostat and a sglt2 inhibitor |
| TW202525278A (zh) * | 2023-12-15 | 2025-07-01 | 愛爾蘭商阿斯特捷利康愛爾蘭有限公司 | 治療慢性腎病及高血壓之方法 |
| US20250255851A1 (en) * | 2024-02-14 | 2025-08-14 | Boehringer Ingelheim International Gmbh | Solid forms of an aldosterone synthase inhibitor |
| WO2025190858A1 (en) * | 2024-03-12 | 2025-09-18 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitor for treating heart failure |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008959A1 (fr) | 1992-10-20 | 1994-04-28 | Taisho Pharmaceutical Co., Ltd. | Derive de prostaglandine |
| AU714033B2 (en) | 1996-07-19 | 1999-12-16 | Nissan Chemical Industries Ltd. | Method for producing purified epoxy compound |
| AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
| ZA200500918B (en) | 2002-10-15 | 2006-12-27 | Otsuka Pharma Co Ltd | 1-substituted 4-nitroimidazole compound and process for producing the same |
| CA2494710C (en) | 2002-10-15 | 2011-05-03 | Otsuka Pharmaceutical Co., Ltd. | 1-substituted-4-nitroimidazole compound and method for preparing the same |
| EP1996588A4 (en) | 2006-03-03 | 2011-10-05 | Torrent Pharmaceuticals Ltd | NEW DUAL ACTION RECEPTOR (DARA) ANTAGONISTS OF ATI AND ETA RECEPTORS |
| EP2001866A2 (en) | 2006-03-29 | 2008-12-17 | Novartis AG | Organic compounds |
| TW200808813A (en) | 2006-04-12 | 2008-02-16 | Speedel Experimenta Ag | Imidazo compounds |
| JP2007297305A (ja) | 2006-04-28 | 2007-11-15 | Daiso Co Ltd | Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法 |
| CA2660701A1 (en) | 2006-08-25 | 2008-03-06 | Novartis Ag | Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| WO2010016987A1 (en) | 2008-08-05 | 2010-02-11 | Dow Global Technologies Inc. | Production of solid epoxy resin |
| US20110172217A1 (en) | 2008-09-05 | 2011-07-14 | Shionogi & Co., Ltd. | Ring-fused morpholine derivative having pi3k-inhibiting activity |
| TW201026688A (en) | 2008-10-07 | 2010-07-16 | Schering Corp | Benzodioxan analogues as alpha2C adrenergic receptor modulators |
| WO2010107768A1 (en) | 2009-03-18 | 2010-09-23 | Schering Corporation | Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| CA2761009A1 (en) | 2009-05-04 | 2010-11-11 | Plexxikon, Inc. | Compounds and methods for inhibition of renin, and indications therefor |
| NZ596302A (en) | 2009-05-15 | 2014-01-31 | Novartis Ag | Aryl pyridine as aldosterone synthase inhibitors |
| BR112012002214B1 (pt) | 2009-07-31 | 2022-01-25 | Global Alliance For Tb Drug Development | Análogos de nitroimidazooxazina e nitroimidazooxazol, seus usos e composição farmacêutica |
| US8541404B2 (en) | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
| HRP20192323T1 (hr) | 2011-09-15 | 2020-03-20 | F. Hoffmann - La Roche Ag | Novi derivati dihidrokinolin-2-ona |
| US9353081B2 (en) | 2011-09-23 | 2016-05-31 | Hoffmann-La Roche Inc. | Bicyclic dihydroquinoline-2-one derivatives |
| AR088989A1 (es) | 2011-11-30 | 2014-07-23 | Hoffmann La Roche | Derivados biciclicos de dihidroisoquinolin-1-ona |
| HRP20171996T1 (hr) | 2012-04-17 | 2018-02-09 | F. Hoffmann - La Roche Ag | Novi derivati fenil-tetrahidroizokinolina |
| KR102096927B1 (ko) | 2012-09-04 | 2020-04-06 | 삼성전자주식회사 | 제어 채널 엘리먼트들에 대한 어그리게이션 레벨들 개수 조정 장치 및 방법 |
| CA2886117C (en) | 2012-10-05 | 2022-05-31 | Merck Sharp & Dohme Corp. | Indoline compounds and their use as aldosterone synthase inhibitors |
| US8912341B2 (en) | 2013-01-16 | 2014-12-16 | Northwestern University | Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones |
| KR20150118158A (ko) | 2013-02-22 | 2015-10-21 | 머크 샤프 앤드 돔 코포레이션 | 항당뇨병 비시클릭 화합물 |
| WO2014168861A2 (en) | 2013-04-08 | 2014-10-16 | Cowans Kenneth W | Air supply concepts to improve efficiency of vcrc engines |
| EP4678242A3 (en) | 2013-04-18 | 2026-03-18 | Boehringer Ingelheim International GmbH | Pharmaceutical composition, methods for treating and uses thereof |
| JP6067181B2 (ja) | 2013-04-30 | 2017-01-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アルドステロンシンターゼ阻害薬 |
| JP6471153B2 (ja) | 2013-10-17 | 2019-02-13 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | アルドステロン合成酵素阻害剤としての新規フェニルジヒドロピリジン誘導体 |
| KR20160100408A (ko) | 2014-01-06 | 2016-08-23 | 리젠 파마슈티컬스 소시에떼 아노님 | 신규한 글루타미나제 저해제 |
| HUE039981T2 (hu) | 2014-07-24 | 2019-02-28 | Boehringer Ingelheim Int | Aldoszteron szintáz inhibitorok |
| WO2016061161A1 (en) | 2014-10-15 | 2016-04-21 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors |
| WO2016119706A1 (zh) | 2015-01-29 | 2016-08-04 | 南京明德新药研发股份有限公司 | 抗肺结核病的硝基咪唑衍生物 |
| US10155765B2 (en) | 2015-03-12 | 2018-12-18 | Merck Sharp & Dohme Corp. | Carboxamide inhibitors of IRAK4 activity |
| KR20190084096A (ko) | 2016-11-10 | 2019-07-15 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
| CN109053637B (zh) | 2018-08-14 | 2021-03-16 | 杭州泽旺生物科技有限公司 | 尺蠖类性信息素及其中间体的合成方法 |
-
2022
- 2022-12-13 TW TW111147688A patent/TW202339719A/zh unknown
- 2022-12-13 CA CA3236890A patent/CA3236890A1/en active Pending
- 2022-12-13 JP JP2024534762A patent/JP2025500826A/ja active Pending
- 2022-12-13 AR ARP220103413A patent/AR127948A1/es not_active Application Discontinuation
- 2022-12-13 CN CN202280082162.7A patent/CN118401241A/zh active Pending
- 2022-12-13 EP EP22850783.6A patent/EP4447961A1/en active Pending
- 2022-12-13 US US18/079,904 patent/US12263157B2/en active Active
- 2022-12-13 AU AU2022415313A patent/AU2022415313A1/en active Pending
- 2022-12-13 KR KR1020247023466A patent/KR20240122521A/ko active Pending
- 2022-12-13 WO PCT/US2022/052631 patent/WO2023114170A1/en not_active Ceased
- 2022-12-13 MX MX2024007335A patent/MX2024007335A/es unknown
-
2024
- 2024-05-16 CL CL2024001470A patent/CL2024001470A1/es unknown
- 2024-10-29 US US18/930,470 patent/US20250049763A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025500826A5 (https=) | ||
| JP2020189864A5 (https=) | ||
| JP2022121594A5 (https=) | ||
| JP2021102643A5 (https=) | ||
| JP2004514663A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| US11351191B2 (en) | Silicate containing compositions and methods of treatment | |
| JP2013545730A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2010530881A5 (https=) | ||
| CN104968358B (zh) | 涉及粘液素的疾病治疗 | |
| RU2013108857A (ru) | Соединения для лечения/профилактики воспалительных глазных заболевний | |
| JP2022519744A5 (https=) | ||
| JP2022119852A5 (https=) | ||
| US11680067B2 (en) | Small molecules for the treatment of primary cancer and cancer metastasis | |
| US20180044368A1 (en) | Gemcitabine derivatives | |
| JP5882296B2 (ja) | 創傷の予防及び治療のための組成物及び方法 | |
| JP2022502378A5 (https=) | ||
| CN1151793C (zh) | 多发性骨髓瘤的骨病变治疗用医药组合物 | |
| RU2002102076A (ru) | Фармацевтическая композиция, содержащая сибутрамин и орлистат | |
| CN115487177B (zh) | 一种黄酮类化合物用于治疗溃疡性结肠炎的新用途 | |
| JP2022521474A5 (https=) | ||
| CN1822841A (zh) | 抗冠状病毒剂 | |
| JP2015531355A (ja) | 腫瘍治療のための薬剤組成物及びその適用 | |
| RU2014143232A (ru) | Соединения для применения в лечении нейробластомы, саркомы юинга или рабдомиосаркомы |